Ryan Widau to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Ryan Widau has written about Randomized Controlled Trials as Topic.
Connection Strength
0.038
-
Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials. Clin Cancer Res. 2022 06 01; 28(11):2297-2305.
Score: 0.038